Hansa Biopharma AB (publ) Intangible Assets

As of the most recent data (June 2026), HNSBF shows a intangible assets of $240M. That compares with $240M in the prior-year period — up 0.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HNSBF's intangible assets is now $240M (was $240M) — a 0.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Hansa Biopharma AB (publ) is outperforming or lagging.

Tracking HNSBF's intangible assets over time shows whether Hansa Biopharma AB (publ) is scaling, shrinking, or reshaping that part of the business. The current reading is $240M That compares with $240M in the prior-year period — up 0.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Hansa Biopharma AB (publ)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $240M) with ownership activity and broader fundamentals.

Hansa Biopharma AB (publ)'s intangible assets is $240M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.